Sign in
8-K

Current Report

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-09-001530

Material agreement · Delisting notice · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 3.02 Unregistered sales of equity securities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading c56987_8k.htm…